Other Income & Expense

Other Income (Expense)

Zimmer Biomet Holdings Other Income (Expense) decreased by 119.5% to -$3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 203.4%, from $2.90M to -$3.00M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a -41.6% CAGR.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026May 1, 2026

How to read this metric

An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.

Detailed definition

Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...

Peer comparison

Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.

Metric ID: other_income_expense_net

Historical Data

19 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$8.00M$300.00K-$56.10M-$42.60M-$25.40M-$3.90M$7.70M-$1.20M$3.80M-$19.60M-$100.00K$2.00M$5.10M-$38.10M$2.90M$3.90M$3.30M$15.40M-$3.00M
QoQ Change-96.3%<-999%+24.1%+40.4%+84.6%+297.4%-115.6%+416.7%-615.8%+99.5%>999%+155.0%-847.1%+107.6%+34.5%-15.4%+366.7%-119.5%
YoY Change-632.5%<-999%+113.7%+97.2%+115.0%-402.6%-101.3%+266.7%+34.2%-94.4%>999%+95.0%-35.3%+140.4%-203.4%
Range-$56.10M$15.40M
CAGR-19.6%
Avg YoY Growth-411.6%
Median YoY Growth+34.2%

Frequently Asked Questions

What is Zimmer Biomet Holdings's other income (expense)?
Zimmer Biomet Holdings (ZBH) reported other income (expense) of -$3.00M in Q1 2026.
How has Zimmer Biomet Holdings's other income (expense) changed year-over-year?
Zimmer Biomet Holdings's other income (expense) decreased by 203.4% year-over-year, from $2.90M to -$3.00M.
What is the long-term trend for Zimmer Biomet Holdings's other income (expense)?
Over 3 years (2022 to 2025), Zimmer Biomet Holdings's other income (expense) has grown at a -41.6% compound annual growth rate (CAGR), from -$128.00M to $25.50M.
What does other income (expense) mean?
The net result of all income and expenses not related to core business operations.